RAC 2.60% $1.58 race oncology ltd

General Comments / Chat, page-7600

  1. 2,770 Posts.
    lightbulb Created with Sketch. 2459
    Yep, the thing I see is a magnificent opportunity that the market doesn't understand (see a u S b I z discussion) that you can buy at increasingly bargain prices.

    $1B mkt cap potential for AML which has been proven before; historic data recognised by FDA.

    $4-$8B annual revenue potential ++ for cardio protect anti-cancer synergy.

    it's like they're selling 911's for $19,990 drive away imho
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.